Nothing Special   »   [go: up one dir, main page]

Skip to main content

Advertisement

Log in

Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neuroinflammation and Neuroplasticity in Patients with Parkinson’s Disease: a Placebo-Controlled Study

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The parallel placebo-controlled study examined the therapeutic effects of dual-target repetitive transcranial magnetic stimulation (rTMS) of the motor cortex (bilaterally) and the left prefrontal cortex (dorsolaterally) on spontaneous and mitogen-stimulating synthesis of pro- and anti-inflammatory cytokines by the blood cells and the level of brain-derived neurotrophic factor (BDNF) in blood serum of patients with Parkinson’s disease. The significantly steeper positive clinical dynamics (assessed by UPRSD scale) observed in rTMS group in comparison with the placebo group was accompanied by a significant drop in spontaneous production of proinflammatory cytokines IFNγ and IL-17A. rTMS produced no significant effect on serum BDNF. The possible mechanisms of rTMS therapeutic action on the level of cytokines associated with neuroinflammation in patients with Parkinson’s disease are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Melnikov MV, Belousova OO, Zhetishev RR, Pashenkov МV, Boyko AN. The influence of catecholamines on Th17-cells in multiple sclerosis. Zh. Nevrol. Psikhiatr. 2016;116(10-2):16-20. Russian.

    Article  CAS  Google Scholar 

  2. Milyukhina IV, Karpenko MN, Klimenko VM. Clinical parameters and the level of certain cytokines in blood and cerebrospinal fluid of patients with Parkinson’s disease. Klin. Med. 2015;93(1):51-55. Russian.

    CAS  Google Scholar 

  3. Aftanas LI, Brack IV, Danilenko KV, Kulikova KI, Dzemidovich SS, Doronin BM. Parkinson’s disease, depression, navigated transcranial magnetic stimulation, dual-target stimulation. Brain Stimulaton. 2017;10(2):486.

    Article  Google Scholar 

  4. Chervyakov AV, Chernyavsky AY, Sinitsyn DO, Piradov MA. Possible mechanisms underlying the therapeutic effects of transcranial magnetic stimulation. Front. Hum. Neurosci. 2015;9:303. doi: https://doi.org/10.3389/fnhum.2015.00303.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Etiévant A, Manta S, Latapy C, Magno LA, Fecteau S, Beaulieu JM. Repetitive transcranial magnetic stimulation induces long-lasting changes in protein expression and histone acetylation. Sci. Rep. 2015;5. ID 16873. doi: https://doi.org/10.1038/srep16873.

  6. Goodwill AM, Lum JAG, Hendy AM, Muthalib M, Johnson L, Albein-Urios N, Teo WP. Using non-invasive transcranial stimulation to improve motor and cognitive function in Parkinson’s disease: a systematic review and meta-analysis. Sci. Rep. 2017;7(1). ID 14840. doi: https://doi.org/10.1038/s41598-017-13260-z.

  7. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-442.

    Article  PubMed  CAS  Google Scholar 

  8. Idova GV, Alperina EL, Cheido MA. Contribution of brain dopamine, serotonin and opioid reсeptors in the mechanisms of neuroimmunomodulation: evidence from pharmacological analysis. Int. Immunopharmacol. 2012;12(4):618-625.

    Article  PubMed  CAS  Google Scholar 

  9. Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Foly N, Hamdy A. Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson’s disease: preliminary results. Mov. Disord. 2007;22(7):1046-1050.

    Article  PubMed  Google Scholar 

  10. Matsumoto A, Ohta N, Goto Y, Kashiwa Y, Yamamoto S, Fujino Y. Haloperidol suppresses murine dendritic cell maturation and priming of the T helper 1-type immune response. Anesth. Analg. 2015;120(4):895-902.

    Article  PubMed  CAS  Google Scholar 

  11. Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS. Involvement of interferongamma in microglial-mediated loss of dopaminergic neurons. J. Neurosci. 2007;27(12):3328-3337.

    Article  PubMed  CAS  Google Scholar 

  12. Okada K, Matsunaga K, Yuhi T, Kuroda E, Yamashita U, Tsuji S. The long-term high-frequency repetitive transcranial magnetic stimulation does not induce mRNA expression of inflammatory mediators in the rat central nervous system. Brain Res. 2002;957(1):37-41.

    Article  PubMed  CAS  Google Scholar 

  13. Schaller G, Sperling W, Richter-Schmidinger T, Mühle C, Heberlein A, Maihöfner C, Kornhuber J, Lenz B. Serial repetitive transcranial magnetic stimulation (rTMS) decreases BDNF serum levels in healthy male volunteers. J. Neural Transm. (Vienna). 2014;121(3):307-313.

    Article  PubMed  CAS  Google Scholar 

  14. Tahmasebinia F, Pourgholaminejad A. The role of Th17 cells in auto-inflammatory neurological disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2017;79(Pt B):408-416.

    CAS  Google Scholar 

  15. Yang X, Song L, Liu Z. The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson’s disease. Neuroreport. 2010;21(4):268-272.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. I. Aftanas.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 165, No. 2, pp. 155-159, February, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aftanas, L.I., Gevorgyan, M.M., Zhanaeva, S.Y. et al. Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neuroinflammation and Neuroplasticity in Patients with Parkinson’s Disease: a Placebo-Controlled Study. Bull Exp Biol Med 165, 195–199 (2018). https://doi.org/10.1007/s10517-018-4128-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4128-4

Key Words

Navigation